Autism & Developmental

Zebrafish embryonically exposed to valproic acid present impaired retinal development and sleep behavior.

DeOliveira-Mello et al. (2023) · Autism research : official journal of the International Society for Autism Research 2023
★ The Verdict

Valproic acid zebrafish mimic the lifelong sleep problems seen in autistic clients.

✓ Read this if BCBAs who write sleep protocols for autistic learners of any age.
✗ Skip if Clinicians only treating daytime skills with no sleep goals.

01Research in Context

01

What this study did

Bassette et al. (2023) gave zebrafish embryos valproic acid. This drug is known to raise autism risk in humans.

The team watched the fish grow. They checked eye development and tracked sleep-like behavior.

02

What they found

The drug slowed eye growth. The fish also slept less and moved more at night.

Fewer sleep-control neurons formed in their tiny brains. These cells normally make serotonin to trigger rest.

03

How this fits with other research

Ma et al. (2026) found similar sleep trouble in kids. Children with autism had shorter REM sleep and took longer to enter it.

Ballester et al. (2019) saw the same pattern in adults. Adults with autism plus intellectual disability slept worse and woke more.

All three studies point to one theme: autism-linked sleep problems start early and last a lifetime.

04

Why it matters

You now have a simple animal model that mirrors the sleep issues you see in clients. Use it to explain why good sleep hygiene is tough for learners with autism. Start sleep assessments early and keep them on the behavior plan. Track night waking and latency data the same way you track manding or SIB. The fish tell us the biology is stubborn, so your intervention must be steady and long-term.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Add a nightly sleep latency probe to your data sheet and teach parents to log wake-ups.

02At a glance

Intervention
not applicable
Design
other
Population
not specified
Finding
negative

03Original abstract

Prenatal exposure to valproic acid (VPA), a drug widely used to treat epilepsy and bipolar disorder, is an environmental risk factor for autism spectrum disorder (ASD). VPA has been used to reproduce the core symptoms of ASD in animal model organisms, including zebrafish. Visual system functioning is essential in the interpretation of social conditions and plays an important role of several behavioral responses. We hypothesized that behavioral deficits displayed by ASD patients may involve impaired visual processing. We used zebrafish as model organism to investigate the visual system after embryonic exposure to VPA using histological, behavioral and gene expression analysis. We analyzed the pineal gland of zebrafish and sleep-like behavior to study how VPA exposure alters photo-sensibility of zebrafish. VPA-exposed zebrafish showed a delay in the development of the retina and optic nerve, which normalized at five days post fertilization. At larval stage, VPA-exposed zebrafish showed sleep disturbances associated with a reduced number of serotonin-producing cells of the pineal gland. In addition, the number of hypocretin/orexin (hcrt) expressing neurons in the rostral hypothalamus at 6 and 14 days post fertilization was reduced. In conclusion, we demonstrated that although VPA exposure leads to a delay in visual system development, it does not affect larval visual function. The novel finding that VPA alters significantly cells involved in sleep regulation and the sleep-like state itself may be relevant for understanding sleep disturbances in ASD patients.

Autism research : official journal of the International Society for Autism Research, 2023 · doi:10.1002/aur.3010